AiCuris is opening first study centers in Germany for its international pivotal phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised patients

Written by Andreas Villaester on 14th June 2022. Posted in Client News.

• Previous
• Next